Evidence map›Paper›PMID 35818434›Full record

ArticleRisk management and healthcare policy2022

Understanding Physicians' Perceptions of Patient-Identified Barriers to Osteoporosis Medication Initiation: A Cognitive Mapping Approach.

Haiyan Qu, Stuart L Silverman, Richard M Shewchuk, Jeffrey R Curtis, Shamly Austin, Susan L Greenspan, Jeri W Nieves, Ryan C Outman, Amy H Warriner, Nelson B Watts and 1 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Risk management and healthcare policy, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Role of bisphosphonates in osteoporosis caused by adult growth hormone deficiency.Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 1 country.

Haiyan QuDepartment of Health Services Administration, University of Alabama at Birmingham, Birmingham, AL, USA.ORCID 0000-0002-0044-589X
Stuart L SilvermanCedars-Sinai, Los Angeles, CA, USA.
Richard M ShewchukDepartment of Health Services Administration, University of Alabama at Birmingham, Birmingham, AL, USA.
Jeffrey R CurtisDepartment of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.
Shamly AustinResearch, Development, & Analytics, Highmark Wholecare, Pittsburgh, PA, USA.
Susan L GreenspanDivision of Geriatric Medicine, University of Pittsburgh, Pittsburgh, PA, USA.
Jeri W NievesDepartment of Epidemiology, Columbia University, New York, NY, USA.
Ryan C OutmanDepartment of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.
Amy H WarrinerDepartment of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.
Nelson B WattsMercy Health, Cincinnati, OH, USA.
Kenneth G SaagDepartment of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.
University of Alabama at Birmingham · USCedars-Sinai Medical Center · USColumbia University · USHighmark Blue Cross Blue Shield · USMercy Health · USUniversity of Pittsburgh · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: Interventions to initiate medication and increase adherence for postmenopausal women who have had a fragility fracture were not always successful. The purpose of this study was to derive an empirical framework for patient-identified barriers to osteoporosis medication initiation and adherence from physician experts. Methods: A cognitive mapping approach involving nominal group technique (NGT) meetings and a card sorting and rating task were used to obtain formative data. We first conducted four NGT meetings with 18 women patients who were not on osteoporosis treatment to identify barriers to osteoporosis medication, then invited 27 osteoporosis physicians to sort and rate 25 patients identified barriers. Descriptive analysis, multidimensional scaling analysis, and hierarchical cluster analysis were applied for data analysis. Results: A two-dimensional five-cluster cognitive map was derived to provide an organizational framework for understanding patients perceived barriers to medication initiation and adherence. The five clusters were concerns about side effects, experience of side effects, lifestyle changes, medication access and complexity, and patient uncertainty about treatment and trust in the provider. The two dimensions were interpreted as internal to patients (X-axis) and external to patients (Y-axis). Conclusions/Implications: Views of patients solicited in a structured format provided directions to help in designing interventions to improve osteoporosis medication initiation and adherence.

Indexed as

cognitive mappingmedication adherencemedication initiationnominal group techniqueosteoporosis treatmentpatient barriers

Identifiers

PMID35818434
PMCPMC9270903
OpenAlexW4283816977

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.